Clinical trial
Fomepizole Dosing During Continuous Renal Replacement Therapy (CRRT)
NCT04649138 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fomepizole Dosing During Continuous Renal Replacement Therapy (CRRT)
- Lead sponsor
- Oslo University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 13, 2019
- Completion date
- November 26, 2020
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
toxic alcohol poisoning